The Controversial History of Hormone Replacement Therapy

被引:129
|
作者
Cagnacci, Angelo [1 ]
Venier, Martina [1 ]
机构
[1] Azienda Sanit Univ Integrata, Obstet & Gynecol Unit, I-33100 Udine, Italy
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 09期
关键词
hormone replacement therapy; osteoporosis; breast cancer; cardiovascular disease; BREAST-CANCER INCIDENCE; CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; MEDROXYPROGESTERONE ACETATE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FRACTURE INCIDENCE; RANDOMIZED-TRIAL;
D O I
10.3390/medicina55090602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the first results of the Women's Health Initiative (WHI) in 2002, which showed that HRT had more detrimental than beneficial effects, HRT use dropped. The negative results of the study received wide publicity, creating panic among some users and new guidance for doctors on prescribing HRT. The clear message from the media was that HRT had more risks than benefits for all women. In the following years, a reanalysis of the WHI trial was performed, and new studies showed that the use of HRT in younger women or in early postmenopausal women had a beneficial effect on the cardiovascular system, reducing coronary disease and all-cause mortality. Notwithstanding this, the public opinion on HRT has not changed yet, leading to important negative consequences for women's health and quality of life.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women
    Baek, Jin Kyung
    Kim, Hee Yon
    Kang, Min Jin
    Choi, Eun A.
    Lee, Jae Kyung
    Kim, Eui Hyeok
    Seo, Seok Kyo
    CLIMACTERIC, 2024, 27 (04) : 406 - 412
  • [22] Use of Hormone Replacement Therapy in Special Circumstances
    Goel, Neerja
    Ranjan, Megha
    Sharma, Jai Bhagwan
    Srivastava, Ruchi
    Vardhan, Shailza
    JOURNAL OF MID-LIFE HEALTH, 2025, 16 (01) : 6 - 13
  • [23] Hormone replacement therapy - where are we now?
    Langer, R. D.
    Hodis, H. N.
    Lobo, R. A.
    Allison, M. A.
    CLIMACTERIC, 2021, 24 (01) : 3 - 10
  • [24] Cardiovascular aspects of menopausal hormone replacement therapy
    Rosano, G. M. C.
    Vitale, C.
    Fini, M.
    CLIMACTERIC, 2009, 12 : 41 - 46
  • [25] Benefits of hormone replacement therapy - Overview and update
    Alsina, JC
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 1997, 42 : 329 - 346
  • [26] Hormone replacement therapy in women with a history of breast cancer
    Ylikorkala, O
    Metsä-Heikkilä, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2002, 16 (06) : 469 - 478
  • [27] THE HISTORY AND RATIONALE OF HORMONE REPLACEMENT THERAPY
    VANKEEP, PA
    MATURITAS, 1990, 12 (03) : 163 - 170
  • [28] Is postmenopausal hormone replacement therapy suitable after a cardio- or cerebrovascular event?
    Windler, Eberhard
    Stute, Petra
    Ortmann, Olaf
    Mueck, Alfred O.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (01) : 213 - 217
  • [29] Hormone replacement therapy: An update
    Kousta, E.
    Tolis, G.
    ARCHIVES OF HELLENIC MEDICINE, 2010, 27 (05): : 776 - 782
  • [30] Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy
    D'Alonzo, Marta
    Bounous, Valentina Elisabetta
    Villa, Michela
    Biglia, Nicoletta
    MEDICINA-LITHUANIA, 2019, 55 (09):